11th May 2018 11:35
LONDON (Alliance News) - Pharmaceutical company Nuformix PLC said Friday that it has appointed Christopher Blackwell, the former chief executive officer of Vectura Group PLC, as non-executive director of the company with immediate effect.
Nuformix Chief Executive Dan Gooding said Blackwell will provide "invaluable experience" to the board and called him a "perfect fit" for the company's development goals. He added that Blackwell's arrival demonstrated "the impact Nuformix hopes to achieve in the commercialisation of [its] product pipeline."
Blackwell is currently executive chairman of Cercadian Therepeutics.
Nuformix shares were up 3.5% at 3.68 pence per share Friday.
Related Shares:
VEC.LNuformix